Depreciation

Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Monday, March 11, 2024

“Bringing together our dedicated, world-class team of acknowledged strategic and clinical experts has enabled us to position Ocular as a leader in retinal care.

Key Points: 
  • “Bringing together our dedicated, world-class team of acknowledged strategic and clinical experts has enabled us to position Ocular as a leader in retinal care.
  • Total net revenue was $14.8 million for the fourth quarter of 2023, a 5.0% increase over total net revenue of $14.1 million in the comparable period in 2022, driven by DEXTENZA sales.
  • General and administrative expenses were $8.0 million for the fourth quarter of 2023 versus $8.3 million in the comparable quarter of 2022, lower primarily due to a reduction of professional-related fees and other expenses.
  • Non-cash charges for stock-based compensation and depreciation and amortization were $5.3 million in the fourth quarter of 2023 versus $4.7 million for the comparable quarter in 2022.

RE Cost Seg Hires Zac Prince as CEO

Retrieved on: 
Monday, March 11, 2024

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- RE Cost Seg, a leading provider of cost segregation studies for real estate investors, is proud to announce the appointment of Zac Prince as CEO.

Key Points: 
  • NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- RE Cost Seg, a leading provider of cost segregation studies for real estate investors, is proud to announce the appointment of Zac Prince as CEO.
  • Zac was formerly the Founder and CEO of BlockFi, a cryptocurrency financial services business that grew rapidly to a $3B valuation and >500M in annual revenue.
  • RE Cost Seg is committed to democratizing access to cost segregation studies by delivering them at price points accessible to single-family, short-term rental, and single-apartment real estate owners.
  • “We’re thrilled to have Zac join the team at RE Cost Seg; his experience leading high-growth teams in technology businesses will be a significant value add for the next phase of RE Cost Seg’s growth and expansion.

Extendicare Announces 2023 Fourth Quarter and Year End Results

Retrieved on: 
Friday, March 8, 2024

MARKHAM, Ontario, March 07, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2023.

Key Points: 
  • MARKHAM, Ontario, March 07, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2023.
  • Beds under management through Extendicare Assist grew 64.2% to 9,783 from Q4 2022 driven by the Revera and Axium transactions.
  • “Our strong fourth quarter is the result of the strategic initiatives we have undertaken to reposition Extendicare for growth and value creation,” said Dr. Michael Guerriere, President and Chief Executive Officer.
  • In November 2023, Axium Extendicare LTC II LP (“Axium JV II”) acquired a new 320-bed LTC redevelopment project in Ottawa from Revera.

The Joint Corp. Reports Fourth Quarter and Year-end 2023 Financial Results

Retrieved on: 
Thursday, March 7, 2024

SCOTTSDALE, Ariz., March 07, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, reported its financial results for the quarter and year ended December 31, 2023.

Key Points: 
  • As we advance our vision to be the Champions of Chiropractic, we expect to generate value for all of our stakeholders.”
    Financial Results for Fourth Quarter Ended December 31: 2023 Compared to 2022
    Revenue was $30.6 million in the fourth quarter of 2023, compared to $27.7 million in the fourth quarter of 2022.
  • Adjusted EBITDA was $4.0 million for both the fourth quarter of 2023 and 2022.
  • Financial Results for Year Ended December 31: 2023 Compared to 2022
    Revenue was $117.7 million in 2023, compared to $101.3 million in 2022.
  • ET on Thursday, March 7, 2024 to discuss the fourth quarter and year-end 2023 financial results.

FAT BRANDS INC. REPORTS FISCAL FOURTH QUARTER AND FULL FISCAL YEAR 2023 FINANCIAL RESULTS

Retrieved on: 
Thursday, March 7, 2024

LOS ANGELES, March 07, 2024 (GLOBE NEWSWIRE) -- FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT) (“FAT Brands” or the “Company”) today reported fiscal fourth quarter and full fiscal year 2023 financial results for the fiscal year ended December 31, 2023.

Key Points: 
  • Brands Inc. (NASDAQ: FAT) (“FAT Brands” or the “Company”) today reported fiscal fourth quarter and full fiscal year 2023 financial results for the fiscal year ended December 31, 2023.
  • “With the acquisition of Smokey Bones early in the fourth quarter, we have grown the FAT Brands portfolio to 18 iconic restaurant brands with annualized system wide sales of $2.5 billion,” said Andy Wiederhorn, Chairman of FAT Brands.
  • Advertising expenses increased $2.2 million in the fiscal fourth quarter of 2023 compared to the prior fiscal year period.
  • FAT Brands will host a conference call and webcast to discuss its fiscal fourth quarter 2023 financial results today at 5:00 PM ET.

NCS Multistage Holdings, Inc. Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, March 7, 2024

HOUSTON, March 07, 2024 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (Nasdaq: NCSM) (the “Company,” “NCS,” “we” or “us”), a leading provider of highly engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies, today announced its results for the quarter and year ended December 31, 2023.

Key Points: 
  • Total revenues were $35.2 million for the quarter ended December 31, 2023, a decrease of 12% compared to the fourth quarter of 2022.
  • Gross profit was $12.3 million, or a gross margin of 35%, for the fourth quarter of 2023, compared to $15.6 million, or 39%, for the fourth quarter of 2022.
  • Other income was $0.4 million for the fourth quarter of 2023 as compared to $1.4 million for the fourth quarter of 2022.
  • Consequently, we reversed our previously recorded litigation provision of $40.8 million during the fourth quarter of 2023.

Gevo Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Thursday, March 7, 2024

ENGLEWOOD, Colo., March 07, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”) today announced financial results for the fourth quarter and full year 2023 and recent corporate highlights.

Key Points: 
  • ENGLEWOOD, Colo., March 07, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”) today announced financial results for the fourth quarter and full year 2023 and recent corporate highlights.
  • Net-Zero 1 and 2024 Expected Uses of Cash: We ended the fourth quarter with cash, cash equivalents, and restricted cash of $375.6 million.
  • Verity: In the third quarter of 2023, our Verity Tracking platform went live with farmers in South Dakota and Minnesota.
  • Gevo NW Iowa RNG generated positive, stand-alone non-GAAP cash EBITDA1 of $1.3 million for the fourth quarter.

El Pollo Loco Holdings, Inc. Announces Fourth Quarter 2023 Financial Results

Retrieved on: 
Thursday, March 7, 2024

COSTA MESA, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- El Pollo Loco Holdings, Inc. (Nasdaq: LOCO) today announced financial results for the 13-week period ended December 27, 2023.

Key Points: 
  • COSTA MESA, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- El Pollo Loco Holdings, Inc. (Nasdaq: LOCO) today announced financial results for the 13-week period ended December 27, 2023.
  • Income from operations in the fourth quarter of 2023 was $7.5 million, compared to $9.5 million in the fourth quarter of 2022.
  • General and administrative expenses in the fourth quarter of 2023 was $10.6 million, compared to $9.6 million in the fourth quarter of 2022.
  • The Company will host a conference call to discuss financial results for the fourth quarter of 2023 today at 4:30 PM Eastern Time.

Team, Inc. Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, March 7, 2024

Announced fourth quarter 2023 revenues of $214.1 million, up 1.3% over the 2022 fourth quarter revenue of $211.3 million.

Key Points: 
  • Announced fourth quarter 2023 revenues of $214.1 million, up 1.3% over the 2022 fourth quarter revenue of $211.3 million.
  • Reported fourth quarter 2023 net loss of $23.1 million, a $33.8 million improvement from the 2022 fourth quarter net loss of $56.9 million.
  • Our fourth quarter and full year results demonstrated tangible progress against those goals through an expanded Adjusted EBITDA margin and, for the fourth quarter, $8.1 million of positive Free Cash Flow.
  • Consolidated Adjusted EBITDA, a non-GAAP measure, was $9.7 million for the fourth quarter of 2023 up 45.1% compared to $6.7 million for the prior-year quarter.

Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance

Retrieved on: 
Thursday, March 7, 2024

Reduced cash used to $6.4 million in the fourth quarter of 2023 compared to $10.0 million used in the third quarter of 2023, a decrease of 36%, and $14.8 million used in the fourth quarter of 2022, a decrease of 57%.

Key Points: 
  • Reduced cash used to $6.4 million in the fourth quarter of 2023 compared to $10.0 million used in the third quarter of 2023, a decrease of 36%, and $14.8 million used in the fourth quarter of 2022, a decrease of 57%.
  • Gross profit for the fourth quarter of 2023 was $16.0 million compared to $16.9 million in the same period in the prior year.
  • Gross margin for the fourth quarter of 2023 was 85%, compared to 82% in the same period in the prior year.
  • Sight Sciences' management team will host a conference call today, March 7, 2024, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.